Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review

被引:7
|
作者
Jurca, Claudia Maria [1 ,2 ]
Kozma, Kinga [1 ,2 ]
Petchesi, Codruta Diana [1 ,2 ]
Zaha, Dana Carmen [1 ]
Magyar, Ioan [1 ]
Munteanu, Mihai [3 ]
Faur, Lucian [3 ]
Jurca, Aurora [4 ]
Bembea, Dan [5 ]
Severin, Emilia [6 ]
Jurca, Alexandru Daniel [1 ]
机构
[1] Univ Oradea, Fac Med & Pharm, Dept Preclin Disciplines, Oradea 410081, Romania
[2] Cty Emergency Clin Hosp Oradea, Reg Ctr Med Genet Bihor, Oradea 410469, Romania
[3] Univ Oradea, Fac Med & Pharm, Dept Med Disciplines, Oradea 410081, Romania
[4] Univ Oradea, Fac Med & Pharm, Oradea 410081, Romania
[5] Univ Med & Pharm Iuliu Hatieganu, Fac Med, Cluj Napoca 400012, Romania
[6] Univ Med & Pharm Carol Davila, Dept Genet, Bucharest 020021, Romania
关键词
tuberous sclerosis; hamartomas; TSC1; TSC2; epilepsy; type 2 diabetes mellitus; Metformin; MAMMALIAN TARGET; GLUCOSE-UPTAKE; COMPLEX; TSC1; MTOR; CELL; KINASE; EXPRESSION; MANAGEMENT; METFORMIN;
D O I
10.3390/genes14020433
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tuberous sclerosis complex (TSC) is a rare autosomal dominant neurocutaneous syndrome. It is manifested mainly in cutaneous lesions, epilepsy and the emergence of hamartomas in several tissues and organs. The disease sets in due to mutations in two tumor suppressor genes: TSC1 and TSC2. The authors present the case of a 33-year-old female patient registered with the Bihor County Regional Center of Medical Genetics (RCMG) since 2021 with a TSC diagnosis. She was diagnosed with epilepsy at eight months old. At 18 years old she was diagnosed with tuberous sclerosis and was referred to the neurology department. Since 2013 she has been registered with the department for diabetes and nutritional diseases with a type 2 diabetes mellitus (T2DM) diagnosis. The clinical examination revealed: growth delay, obesity, facial angiofibromas, sebaceous adenomas, depigmented macules, papillomatous tumorlets in the thorax (bilateral) and neck, periungual fibroma in both lower limbs, frequent convulsive seizures; on a biological level, high glycemia and glycated hemoglobin levels. Brain MRI displayed a distinctive TS aspect with five bilateral hamartomatous subependymal nodules associating cortical/subcortical tubers with the frontal, temporal and occipital distribution. Molecular diagnosis showed a pathogenic variant in the TSC1 gene, exon 13, c.1270A>T (p. Arg424*). Current treatment targets diabetes (Metformin, Gliclazide and the GLP-1 analog semaglutide) and epilepsy (Carbamazepine and Clonazepam). This case report presents a rare association between type 2 diabetes mellitus and Tuberous Sclerosis Complex. We suggest that the diabetes medication Metformin may have positive effects on both the progression of the tumor associated with TSC and the seizures specific to TSC and we assume that the association of TSC and T2DM in the presented cases is accidental, as there are no similar cases reported in the literature.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways
    Lien, Gi-Shih
    Lin, Chien-Huang
    Yang, You-Lan
    Wu, Ming-Shun
    Chen, Bing-Chang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 776 : 124 - 131
  • [22] Morroniside promotes the osteogenesis by activating PI3K/Akt/mTOR signaling
    Liu, Hui
    Li, Xi
    Lin, Jingui
    Lin, Miaokuo
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2021, 85 (02) : 332 - 339
  • [23] Clinical significance of PI3K/Akt/mTOR signaling in gastric carcinoma
    Jung, Eun-Jung
    Suh, Ja Hee
    Kim, Woo Ho
    Kim, Hee Sung
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (05): : 995 - 1007
  • [24] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [25] Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis
    Ge, Fengmei
    Wang, Fangfang
    Yan, Xiuqing
    Li, Zhao
    Wang, Xuebin
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 5793 - 5798
  • [26] Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
    Serej, Forough Alemi
    Pourhassan-Moghaddam, Mohammad
    Kalan, Mohammad Ebrahimi
    Mehdipour, Ahmad
    Serej, Zeynab Aliyari
    Ebrahimi-Kalan, Abbas
    CRESCENT JOURNAL OF MEDICAL AND BIOLOGICAL SCIENCES, 2018, 5 (01): : 7 - 13
  • [27] IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
    Duan, Shiyu
    Huang, Wenqing
    Liu, Xiaoting
    Liu, Xuming
    Chen, Nana
    Xu, Qiong
    Hu, Yukun
    Song, Wen
    Zhou, Jun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [28] Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
    Rahmani, Farzad
    Ziaeemehr, Aghigh
    Shahidsales, Soodabeh
    Gharib, Masoumeh
    Khazaei, Majid
    Ferns, Gordon A.
    Ryzhikov, Mikhail
    Avan, Amir
    Hassanian, Seyed M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (05) : 4146 - 4152
  • [29] Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
    Stefani, Constantin
    Miricescu, Daniela
    Stanescu-Spinu, Iulia-Ioana
    Nica, Remus Iulian
    Greabu, Maria
    Totan, Alexandra Ripszky
    Jinga, Mariana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [30] PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas
    Rubinfeld, Hadara
    Shimon, Ilan
    ENDOCRINE, 2012, 42 (02) : 285 - 291